Phunware Reports Third Quarter 2023 Financial Results
AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company,” “we,” “us” or “our”), the pioneer o...
Stay updated with breaking news from Reinforce Core. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AUSTIN, Texas, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company,” “we,” “us” or “our”), the pioneer o...
Phunware Announces Wind Down of Lyte Technology's Operations to Reinforce Core Mission
SUZHOU, China, Aug. 25, 2022 /PRNewswire/ -- CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates
SUZHOU, China, June 1, 2022 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today reported 2021 full-year financial results and recent business highlights. Dr. Frank Jiang, CEO of CStone, commented, "As a full-fledged biopharmaceutical company, we achieved significant milestones in 2021. As of...